St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
Launched by MILTON S. HERSHEY MEDICAL CENTER · Oct 11, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called St. Joseph's HPV Self-sampling, is studying whether offering self-sampled HPV tests can help more women participate in cervical cancer screening compared to the traditional method where a healthcare provider takes the sample. The main goals are to see how comfortable patients feel using the self-sampling method and to check how many women complete the test. The study also aims to find out if this self-sampling option increases the overall number of cervical cancer screenings in the patient population at St. Joseph's clinic.
To participate, women must be due for a cervical cancer screening, be able to communicate in English or Spanish, and not be at higher-than-average risk for cervical cancer. This means they should not be pregnant, currently incarcerated, or have serious health issues related to cervical cancer. If you join the trial, you will have the chance to use a self-sampling kit to collect your own sample, which might feel more comfortable for some women. The trial is currently recruiting participants, and getting involved could help improve screening options for others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Eligible but out-of-date for cervical cancer screening
- • Able to speak, read, and communicate well in English or Spanish
- • Not at greater than average risk for cervical cancer
- Exclusion Criteria:
- • Pregnant
- • Incarcerated
- * Greater than average risk for cervical cancer, for example:
- • Already diagnosed with high-grade precancerous cervical cancer or cervical lesions
- • Has a compromised immune system
- • Unable to speak, read, and communicate well in English or Spanish
- • Unable or unwilling to give implied consent or otherwise complete study requirements
About Milton S. Hershey Medical Center
Milton S. Hershey Medical Center, a leading academic medical institution affiliated with Penn State University, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the center leverages its expertise in various medical fields to conduct rigorous clinical studies aimed at improving treatment outcomes and enhancing the understanding of complex health conditions. The facility is committed to ethical research practices and fostering collaboration among multidisciplinary teams, ensuring that participants receive the highest standard of care while contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, Pennsylvania, United States
Patients applied
Trial Officials
Christina Scartozzi, DO
Principal Investigator
Penn State College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials